• 1
    Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109: 173241.
  • 2
    Longstreth GF. Irritable Bowel Syndrome — a multibillion dollar problem. Gastroenterology 1995; 109: 202931.
  • 3
    Whitehead WE, Burnett CK, Cook EW III, Taub E. Impact of Irritable Bowel Syndrome on quality of life. Digestive Dis Sci 1996; 41: 224853.
  • 4
    Jones RH. Clinical economics review — gastrointestinal disease in primary care. Aliment Pharmacol Ther 1996; 10: 2339.
  • 5
    Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics and referral. Gut 2000; 46: 778.
  • 6
    Drossman DA, Li Z, Andruzzi E, et al. UH householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Digestive Dis Sci 1993; 38: 156980.
  • 7
    Talley NJ. Irritable Bowel Syndrome: definition, diagnosis and epidemiology. Clin Gastroenterol 1999; 13(3): 37184.
  • 8
    Jones R, Lydeard S. Irritable Bowel Syndrome in the general population. Br Med J 1991; 304: 8790.
  • 9
    Mearin F, Badia X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in the general population. Scand J Gastroenterol 2001; 36: 115561.
  • 10
    Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 6534.
  • 11
    Drossman DA, Richter JE, Talley NJ, et al., ed. The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment — A Multinational Consensus. Boston: Little Brown and Co, 1994.
  • 12
    Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45: 11437.
  • 13
    Simpson DM, Ezzati-Rice TM, Zell ER. Forty years and four surveys. How does our measuring measure up? Am J Prev Med 2001; 20(S4): 614.
  • 14
    Anderson JE, Nelson DE, Wilson RW. Telephone coverage and measurement of health risk indicators: data from the National Health Interview Survey. Am J Public Health 1998; 88(9): 13925.
  • 15
    Casey PH, Goolsby SL, Lensing SY, Perloff BP, Bogle ML. The use of telephone interview methodology to obtain 24-hour dietary recalls. J Am Diet Assoc 1999; 99(11): 140611.
  • 16
    Kargman DE, Sacco RL, Boden-Albala B, Paik MC, Hauser WA, Shea S. Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan Stroke Study. Neuroepidemiology 1999; 18(4): 17484.
  • 17
    Boyce PM, Kolosky NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000; 95: 17683.
    Direct Link:
  • 18
    Kamm MA. The complexity of drug development for irritable bowel syndrome. Aliment Pharmacol Ther 2002; 16(3): 34351.